Total Payments
$1,354
2024 Payments
$121.31
Companies
27
Transactions
74
Medicare Patients
1,343
Medicare Billing
$136,872
Payment Breakdown by Category
Food & Beverage$1,146 (84.6%)
Education$208.84 (15.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,146 | 69 | 84.6% |
| Education | $208.84 | 5 | 15.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $176.77 | 11 | $0 (2022) |
| Daiichi Sankyo Inc. | $160.63 | 9 | $0 (2023) |
| Incyte Corporation | $111.00 | 4 | $0 (2021) |
| Astellas Pharma US Inc | $83.55 | 2 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $81.74 | 5 | $0 (2021) |
| Amgen Inc. | $70.44 | 4 | $0 (2022) |
| Celgene Corporation | $65.43 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $58.19 | 4 | $0 (2023) |
| Merck Sharp & Dohme LLC | $57.04 | 3 | $0 (2024) |
| EMD Serono, Inc. | $43.80 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $121.31 | 7 | Merck Sharp & Dohme LLC ($57.04) |
| 2023 | $130.60 | 6 | EMD Serono, Inc. ($43.80) |
| 2022 | $174.45 | 11 | Novartis Pharmaceuticals Corporation ($45.37) |
| 2021 | $380.83 | 22 | Daiichi Sankyo Inc. ($125.96) |
| 2020 | $99.12 | 6 | Bayer HealthCare Pharmaceuticals Inc. ($20.47) |
| 2019 | $227.68 | 8 | Incyte Corporation ($83.84) |
| 2018 | $96.48 | 6 | Genentech USA, Inc. ($42.45) |
| 2017 | $123.89 | 8 | Pharmacyclics LLC, An AbbVie Company ($27.67) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $17.65 | General |
| Category: Hematology | ||||||
| 09/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.38 | General |
| 08/26/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Oncology | ||||||
| 07/01/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), REBLOZYL | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: ONCOLOGY | ||||||
| 05/29/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: ONCOLOGY | ||||||
| 04/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Oncology | ||||||
| 01/08/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug), REBLOZYL | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2023 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: Oncology | ||||||
| 12/05/2023 | EMD Serono, Inc. | — | Education | In-kind items and services | $43.80 | General |
| 09/12/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.12 | General |
| 08/31/2023 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Oncology | ||||||
| 08/07/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Iron Deficiency Anemia | ||||||
| 04/10/2023 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/07/2022 | MorphoSys, US Inc. | MONJUVI (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Oncology | ||||||
| 11/02/2022 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $11.93 | General |
| Category: Hematology | ||||||
| 10/27/2022 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $15.93 | General |
| Category: Hematology | ||||||
| 10/26/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: ONCOLOGY | ||||||
| 10/26/2022 | PFIZER INC. | IBRANCE (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: ONCOLOGY | ||||||
| 10/20/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2022 | MorphoSys, US Inc. | MONJUVI (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Oncology | ||||||
| 05/18/2022 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: ONCOLOGY | ||||||
| 05/11/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA, MEKINIST | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: ONCOLOGY | ||||||
| 02/09/2022 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Oncology | ||||||
| 12/17/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Iron Deficiency Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 264 | 382 | $93,562 | $33,101 |
| 2022 | 9 | 350 | 558 | $97,516 | $33,428 |
| 2021 | 9 | 432 | 699 | $115,747 | $42,588 |
| 2020 | 10 | 297 | 526 | $70,337 | $27,756 |
Total Patients
1,343
Total Services
2,165
Medicare Billing
$136,872
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 140 | $35,420 | $12,902 | 36.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 47 | $16,638 | $6,070 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 75 | $13,350 | $4,355 | 32.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 21 | 21 | $9,135 | $3,348 | 36.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 24 | $6,408 | $2,406 | 37.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $6,832 | $1,869 | 27.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,264 | $1,774 | 33.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 32 | 45 | $515.00 | $378.00 | 73.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 165 | $41,745 | $14,412 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 69 | 82 | $14,596 | $4,584 | 31.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 29 | $10,266 | $3,766 | 36.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 18 | 18 | $7,830 | $2,790 | 35.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 17 | $8,296 | $2,513 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $7,238 | $2,489 | 34.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 15 | $4,005 | $1,573 | 39.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 56 | 144 | $2,880 | $1,105 | 38.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 47 | 66 | $660.00 | $195.96 | 29.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 114 | 193 | $48,561 | $18,438 | 38.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 37 | $13,098 | $5,241 | 40.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 28 | 29 | $14,152 | $4,595 | 32.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 36 | 36 | $11,706 | $4,483 | 38.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 19 | 19 | $8,111 | $3,142 | 38.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 57 | 60 | $10,380 | $3,003 | 28.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 16 | 17 | $4,539 | $1,751 | 38.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 75 | 212 | $4,240 | $1,647 | 38.9% |
About Dr. Nicholas Pleat, DO
Dr. Nicholas Pleat, DO is a Hematology & Oncology healthcare provider based in Fairfield, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2011. The National Provider Identifier (NPI) number assigned to this provider is 1609163260.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicholas Pleat, DO has received a total of $1,354 in payments from pharmaceutical and medical device companies, with $121.31 received in 2024. These payments were reported across 74 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($1,146).
As a Medicare-enrolled provider, Pleat has provided services to 1,343 Medicare beneficiaries, totaling 2,165 services with total Medicare billing of $136,872. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Fairfield, OH
- Active Since 07/05/2011
- Last Updated 07/21/2022
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609163260
Products in Payments
- INJECTAFER (Drug) $140.34
- MEKINIST (Drug) $71.65
- KISQALI (Drug) $70.46
- OPDIVO (Biological) $45.66
- KEYTRUDA (Biological) $40.57
- PADCEV (Biological) $39.60
- MONJUVI (Drug) $37.57
- ZEPZELCA (Drug) $36.47
- REBLOZYL (Biological) $33.58
- LIBTAYO (Biological) $33.18
- Pomalyst (Drug) $31.85
- Imbruvica (Drug) $27.67
- Zoladex (Drug) $26.00
- JAKAFI (Drug) $25.38
- Prolia (Biological) $22.43
- Stivarga (Drug) $20.47
- Enhertu (Drug) $20.29
- LUTATHERA (Drug) $20.00
- FOUNDATIONONE (Device) $19.81
- PADCEV (Drug) $18.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Fairfield
Edward Crane, Md, MD
Hematology & Oncology — Payments: $203,023
Hematology & Oncology $203,023
Edward Duda, Md, MD
Hematology & Oncology — Payments: $21,965
Hematology & Oncology $21,965
Sandhya Dhanjal, Md, MD
Hematology & Oncology — Payments: $19,244
Hematology & Oncology $19,244
Yelena Krijanovski, M.d, M.D
Hematology & Oncology — Payments: $6,860
Hematology & Oncology $6,860
Dr. Kanwaldeep Rasila, M.d, M.D
Hematology & Oncology — Payments: $5,934
Hematology & Oncology $5,934
Dr. Prasad Kudalkar, Md, MD
Hematology & Oncology — Payments: $3,232
Hematology & Oncology $3,232